08-23-2024, 06:06 AM
Altraz (anastrozole) is an effective medication used to treat hormone receptor-positive breast cancer in postmenopausal women. Here's how it works:
Aromatase Inhibition: Altraz contains the active ingredient anastrozole, which is a non-steroidal aromatase inhibitor. Aromatase is an enzyme responsible for converting androgens (male hormones) into estrogens (female hormones) in the body.
Estrogen Reduction: By blocking the action of aromatase, Altraz significantly lowers the amount of estrogen produced in the body. Studies have shown that it can reduce estradiol levels by more than 80% in postmenopausal women.
Mechanism of Action: In postmenopausal women, estrogen is produced primarily by converting androstenedione to estrone, which is then converted to estradiol. Altraz interrupts this conversion process by inhibiting the aromatase enzyme.
Breast Cancer Treatment: Lowering estrogen levels is particularly beneficial for treating hormone receptor-positive breast cancer, as these cancers often rely on estrogen for growth. By reducing estrogen, Altraz can help slow or stop the development of breast cancer cells.
Dosage: The recommended dose of Altraz is one 1 mg tablet taken once daily, with or without food. It is important to take it simultaneously each day for optimal results.
By effectively reducing estrogen levels, Altraz plays a crucial role in the treatment of hormone-dependent breast cancer in postmenopausal women. This helps delay the recurrence of early-stage breast cancer and can also be used as a first-line treatment for advanced or metastatic breast cancer.
Have more info: Genericcures.com
Aromatase Inhibition: Altraz contains the active ingredient anastrozole, which is a non-steroidal aromatase inhibitor. Aromatase is an enzyme responsible for converting androgens (male hormones) into estrogens (female hormones) in the body.
Estrogen Reduction: By blocking the action of aromatase, Altraz significantly lowers the amount of estrogen produced in the body. Studies have shown that it can reduce estradiol levels by more than 80% in postmenopausal women.
Mechanism of Action: In postmenopausal women, estrogen is produced primarily by converting androstenedione to estrone, which is then converted to estradiol. Altraz interrupts this conversion process by inhibiting the aromatase enzyme.
Breast Cancer Treatment: Lowering estrogen levels is particularly beneficial for treating hormone receptor-positive breast cancer, as these cancers often rely on estrogen for growth. By reducing estrogen, Altraz can help slow or stop the development of breast cancer cells.
Dosage: The recommended dose of Altraz is one 1 mg tablet taken once daily, with or without food. It is important to take it simultaneously each day for optimal results.
By effectively reducing estrogen levels, Altraz plays a crucial role in the treatment of hormone-dependent breast cancer in postmenopausal women. This helps delay the recurrence of early-stage breast cancer and can also be used as a first-line treatment for advanced or metastatic breast cancer.
Have more info: Genericcures.com